| Year |
Citation |
Score |
| 2023 |
Gupta A, Carnazza M, Jones M, Darzynkiewicz Z, Halicka D, O'Connell T, Zhao H, Dadafarin S, Shin E, Schwarcz MD, Moscatello A, Tiwari RK, Geliebter J. Androgen Receptor Activation Induces Senescence in Thyroid Cancer Cells. Cancers. 15. PMID 37190127 DOI: 10.3390/cancers15082198 |
0.336 |
|
| 2022 |
Dadafarin S, Rodríguez TC, Carnazza MA, Tiwari RK, Moscatello A, Geliebter J. Expression Indicates Lymph Node Metastasis and Presence of Cancer-Associated Fibroblasts in Papillary Thyroid Cancer. Cells. 11. PMID 36231143 DOI: 10.3390/cells11193181 |
0.317 |
|
| 2021 |
Dadafarin S, Carnazza M, Islam HK, Moscatello A, Tiwari RK, Geliebter J. Noncoding RNAs in Papillary Thyroid Cancer: Interaction with Cancer-Associated Fibroblasts (CAFs) in the Tumor Microenvironment (TME) and Regulators of Differentiation and Lymph Node Metastasis. Advances in Experimental Medicine and Biology. 1350: 145-155. PMID 34888848 DOI: 10.1007/978-3-030-83282-7_7 |
0.341 |
|
| 2021 |
Chakraborty S, Carnazza M, Jarboe T, DeSouza N, Li XM, Moscatello A, Geliebter J, Tiwari RK. Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity. Advances in Experimental Medicine and Biology. 1350: 33-66. PMID 34888843 DOI: 10.1007/978-3-030-83282-7_2 |
0.313 |
|
| 2021 |
Jarboe T, Tuli NY, Chakraborty S, Maniyar RR, DeSouza N, Xiu-Min Li, Moscatello A, Geliebter J, Tiwari RK. Inflammatory Components of the Thyroid Cancer Microenvironment: An Avenue for Identification of Novel Biomarkers. Advances in Experimental Medicine and Biology. 1350: 1-31. PMID 34888842 DOI: 10.1007/978-3-030-83282-7_1 |
0.421 |
|
| 2021 |
Jones ME, O'Connell TJ, Zhao H, Darzynkiewicz Z, Gupta A, Buchsbaum J, Shin E, Iacob C, Suslina N, Moscatello A, Schantz S, Tiwari R, Geliebter J. Androgen receptor activation decreases proliferation in thyroid cancer cells. Journal of Cellular Biochemistry. PMID 33876852 DOI: 10.1002/jcb.29934 |
0.384 |
|
| 2020 |
Reyes N, Tiwari R, Geliebter J. Abstract 5591: Differential profiles of pro-inflammatory chemokines identified in patients with prostate cancer and benign prostatic hyperplasia Immunology. 80: 5591-5591. DOI: 10.1158/1538-7445.Am2020-5591 |
0.376 |
|
| 2020 |
Dadafarin S, Carnazza MA, Moscatello A, Tiwari R, Geliebter J. Abstract 2236: Mechanism of androgen-mediated down-regulation of PD-L1 in thyroid cancer Immunology. 80: 2236-2236. DOI: 10.1158/1538-7445.Am2020-2236 |
0.426 |
|
| 2020 |
Chakraborty S, Jarboe T, Dadafarin S, Geliebter J, Moscatello A, Tiwari RK. Abstract 2235: Implications of HVEM/BTLA/LIGHT signaling in anaplastic thyroid cancer Immunology. DOI: 10.1158/1538-7445.Am2020-2235 |
0.391 |
|
| 2019 |
Maniyar R, Freund R, Malhotra A, Chakraborty S, Geliebter J, Wallack M, Tiwari RK. Abstract B174: Co-expression of stimulators and inhibitors of T-cell activation in melanoma Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-B174 |
0.392 |
|
| 2019 |
Reyes N, Rebollo J, Tiwari R, Geliebter J. Abstract 520: Alteration of chemokine gene expression in PC-3 cells treated with NSAIDs Cancer Research. 79: 520-520. DOI: 10.1158/1538-7445.Sabcs18-520 |
0.442 |
|
| 2019 |
Dadafarin S, Gupta A, Dermigny K, Cavdar L, Pecchia B, Jones M, O'Connell T, Rasamny J, Suslina N, Iacob C, Schwarcz M, Kamat A, Budenz C, Berzofsky C, Jourdy D, ... ... Tiwari R, et al. Abstract 3570: Investigating coding and non-coding RNA in papillary thyroid cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-3570 |
0.311 |
|
| 2019 |
Rahoma GB, Maniyar R, Chakraborty S, Singh S, Srinivasan A, Mittelman A, Geliebter J, Tiwari RK. Abstract 3562: Exosomes secreted by AC133+/CD34+cells harbor invasion potentiating miRNAs Cancer Research. 79: 3562-3562. DOI: 10.1158/1538-7445.Sabcs18-3562 |
0.401 |
|
| 2019 |
Chakraborty S, Maniyar RR, Dadafarin S, Rahoma GB, Singh S, Moscatello A, Geliebter J, Tiwari RK. Abstract 3237: Combinatorial immune checkpoint inhibitor therapy in anaplastic thyroid cancer Immunology. DOI: 10.1158/1538-7445.Sabcs18-3237 |
0.414 |
|
| 2019 |
Figueroa S, Tiwari R, Geliebter J, Reyes N. Abstract 4253: Differential expression of protein‐coding and non-coding RNAs in malignant melanoma Cancer Research. 79: 4253-4253. DOI: 10.1158/1538-7445.Am2019-4253 |
0.332 |
|
| 2019 |
Maniyar RR, Chakraborty S, Rahoma GB, Degliuomini JJ, Wallack M, Geliebter J, Tiwari RK. Abstract 3946: Tumor checkpoint inhibitor profiling for an optimal clinical response Cancer Research. 79: 3946-3946. DOI: 10.1158/1538-7445.Am2019-3946 |
0.394 |
|
| 2019 |
Jarboe T, Carnazza M, Chakraborty S, Yang N, Srivastava K, Geliebter J, Tiwari RK, Li X. Abstract 1863: Identification of anticancer agent from antiallergic treatment regimens of traditional Chinese medicine Cancer Research. 79: 1863-1863. DOI: 10.1158/1538-7445.Am2019-1863 |
0.498 |
|
| 2019 |
Chakraborty S, Mo F, Walsh M, Liu C, Cou M, Maniyar R, Rahoma GB, Singh S, Jarboe T, Carnazza M, Tiwari R, Li X. Abstract 1855: Re-purposing traditional Chinese anti-asthma formula ASHMI for triple negative breast cancer Cancer Research. 79: 1855-1855. DOI: 10.1158/1538-7445.Am2019-1855 |
0.447 |
|
| 2018 |
Reyes I, Reyes N, Suriano R, Iacob C, Suslina N, Policastro A, Moscatello A, Schantz S, Tiwari RK, Geliebter J. Gene expression profiling identifies potential molecular markers of papillary thyroid carcinoma. Cancer Biomarkers : Section a of Disease Markers. PMID 30614796 DOI: 10.3233/Cbm-181758 |
0.639 |
|
| 2018 |
Bednarczyk RB, Tuli NY, Hanly EK, Rahoma GB, Maniyar R, Mittelman A, Geliebter J, Tiwari RK. Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer. Oncotarget. 9: 24272-24282. PMID 29849939 DOI: 10.18632/Oncotarget.24917 |
0.41 |
|
| 2018 |
Iacobas DA, Tuli NY, Iacobas S, Rasamny JK, Moscatello A, Geliebter J, Tiwari RK. Gene master regulators of papillary and anaplastic thyroid cancers. Oncotarget. 9: 2410-2424. PMID 29416781 DOI: 10.18632/Oncotarget.23417 |
0.405 |
|
| 2018 |
Tiwari R, Rahoma GB, Tuli N, Bednarczyk R, Maniyar R, Chakraborty S, Singh S, Mittelman A, Geliebter J. Abstract P5-03-06: Novel targets of breast cancer associated with inflammatory tumor microenvironment Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P5-03-06 |
0.451 |
|
| 2018 |
Maniyar RR, Chakraborty S, Tuli NY, Rahoma GB, Singh S, Wallack M, Geliebter J, Tiwari RK. Abstract 714: A case for combining immunotherapy and targeted small molecule inhibitors: Immunoregulation by primary melanoma cells Cancer Research. 78: 714-714. DOI: 10.1158/1538-7445.Am2018-714 |
0.399 |
|
| 2018 |
Gupta A, Singh K, O'Connell TJ, Jones M, Rasamny J, Schwarcz M, Moscatello A, Shin E, Tiwari R, Geliebter J. Abstract 5750: Underlying inflammatory processes in non-neoplastic female thyroid serve as an immunological basis for the sex disparity in papillary thyroid cancer Cancer Research. 78: 5750-5750. DOI: 10.1158/1538-7445.Am2018-5750 |
0.433 |
|
| 2018 |
Chakraborty S, Maniyar RR, Tuli NY, Rahoma GB, Singh S, Kamat A, Berzofsky C, Budenz C, Moscatello A, Geliebter J, Tiwari RK. Abstract 2762: Identification of novel immunotherapeutic targets in anaplastic thyroid cancer Cancer Research. 78: 2762-2762. DOI: 10.1158/1538-7445.Am2018-2762 |
0.458 |
|
| 2018 |
O'Connell TJ, Gupta A, Jones M, Lando T, Jourdy D, Shin E, Moscatello A, Tiwari R, Geliebter J. Abstract 2737: Does androgen attenuation of PD-L1 expression in thyroid cancer modulate disease incidence Cancer Research. 78: 2737-2737. DOI: 10.1158/1538-7445.Am2018-2737 |
0.364 |
|
| 2018 |
Dadafarin S, Gupta A, Dermigny K, Jones M, O'Connell T, Rasamny J, Suslina N, Iacob I, Schwarcz M, Kamat A, Budenz C, Berzofsky C, Jourdy D, Lando T, Schantz S, ... ... Tiwari R, et al. Abstract 2469: Coding and non-coding RNA in papillary thyroid cancer - markers for disease progression Cancer Research. 78: 2469-2469. DOI: 10.1158/1538-7445.Am2018-2469 |
0.425 |
|
| 2018 |
Rahoma GB, Tuli N, Maniyar R, Chakraborty S, Singh S, Mittelman A, Gelibter J, Tiwari RK. Abstract 2053: Exosomes from AC133+/CD34+ stem cells mediate a paracrine effect in breast cancer cells Cancer Research. 78: 2053-2053. DOI: 10.1158/1538-7445.Am2018-2053 |
0.393 |
|
| 2017 |
Chakraborty S, Maniyar RR, Tuli NY, Rahoma GB, Budenz C, Singh S, Geliebter J, Tiwari R. Abstract 5676: Functional pairing of immunomodulatory targets in anaplastic thyroid cancer Cancer Research. 77: 5676-5676. DOI: 10.1158/1538-7445.Am2017-5676 |
0.468 |
|
| 2017 |
O'Connell TJ, Jones M, Gupta A, Lando T, Jourdy D, Shin E, Moscatello A, Tiwari R, Geliebter J. Abstract 5575: Androgen receptor stimulation with 5α-dihydrotestosterone (DHT) decreases PD-L1 expression in androgen-responsive thyroid cancer cells Cancer Research. 77: 5575-5575. DOI: 10.1158/1538-7445.Am2017-5575 |
0.462 |
|
| 2017 |
Gupta A, O'Connell T, Jones M, Singh K, Schwarcz M, Rasamny J, Halicka D, Li J, Iacob C, Suslina N, Schantz S, Shin E, Darzynkiewicz Z, Tiwari R, Geliebter J. Abstract 4356: Methylation and expression of androgen receptor in Papillary Thyroid Cancer Cancer Research. 77: 4356-4356. DOI: 10.1158/1538-7445.Am2017-4356 |
0.397 |
|
| 2017 |
Tuli NY, Kamat A, Maniyar R, Rahoma GB, Chakraborty S, Singh S, Moscatello A, Geliebter J, Tiwari RK. Abstract 3973: Role of thyroid tumor microenvironment secretome in cancer initiation and progression Cancer Research. 77: 3973-3973. DOI: 10.1158/1538-7445.Am2017-3973 |
0.447 |
|
| 2017 |
Maniyar RR, Chakraborty S, Tuli N, Rahoma GB, Singh S, Geliebter J, Wallack M, Tiwari RK. Abstract 3656: Implication for checkpoint therapeutics: Expression of co-stimulatory and co-inhibitory molecules in melanoma cells Cancer Research. 77: 3656-3656. DOI: 10.1158/1538-7445.Am2017-3656 |
0.399 |
|
| 2017 |
Tuli NY, Berzofsky C, Maniyar R, Chakraborty S, Rahoma GB, Singh S, Geliebter J, Tiwari RK, Iacobas S, Iacobas DA. Abstract 3134: Hierarchical gene master regulators of papillary and anaplastic thyroid cancer phenotype Cancer Research. 77: 3134-3134. DOI: 10.1158/1538-7445.Am2017-3134 |
0.407 |
|
| 2016 |
Bednarczyk RB, Tuli NY, Rahoma GB, Maniyar R, Mittelman A, Tiwari RK. Abstract 5105: Exosomes secreted by proinflammatory macrophages modulate breast cancer Cancer Research. 76: 5105-5105. DOI: 10.1158/1538-7445.Am2016-5105 |
0.454 |
|
| 2016 |
Tuli NY, Bednarczyk RB, Rahoma GMB, Moscatello A, Geliebter J, Tiwari RK. Abstract 4089: Thyroid tumor microenvironment: mutual interaction between cancer and inflammatory cells Cancer Research. 76: 4089-4089. DOI: 10.1158/1538-7445.Am2016-4089 |
0.512 |
|
| 2016 |
Maniyar RR, Bednarczyk RB, Rahoma GMB, Tuli N, Mittelman A, Tiwari RK, Suriano R. Abstract 3365: Provasculogenic effects of alcohol and estrogen: implications for breast cancer development Cancer Research. 76: 3365-3365. DOI: 10.1158/1538-7445.Am2016-3365 |
0.628 |
|
| 2016 |
Rahoma GMB, Tuli NY, Bednarczyk RB, Maniyar RR, Mittelman A, Geliebter J, Tiwari R. Abstract 3263: Dietary supplement 3, 3’-diindolylmethane (DIM) as an antiangiogenic agent in breast cancer Cancer Research. 76: 3263-3263. DOI: 10.1158/1538-7445.Am2016-3263 |
0.47 |
|
| 2016 |
O’Connell T, Jones M, Gupta A, Moscatello A, Tiwari RK, Geliebter J. Abstract 3223: Androgen receptor stimulation decreases PD-L1 expression in androgen-responsive thyroid cancer cells Cancer Research. 76: 3223-3223. DOI: 10.1158/1538-7445.Am2016-3223 |
0.457 |
|
| 2016 |
Gupta A, Jones M, O’Connell T, Halicka D, Li J, Zhao H, Moscatello A, Darzynkiewicz Z, Tiwari R, Geliebter J. Abstract 2841: Continuous androgen receptor stimulation in thyroid cancer cells induces irreversible senescence Cancer Research. 76: 2841-2841. DOI: 10.1158/1538-7445.Am2016-2841 |
0.479 |
|
| 2016 |
Maniyar RR, Tuli N, Suriano R, Geliebter J, Wallack M, Tiwari RK. Abstract 2365: Checkpoint inhibitors and a multivalent melanoma vaccine as a novel combinatorial therapy Cancer Research. 76: 2365-2365. DOI: 10.1158/1538-7445.Am2016-2365 |
0.668 |
|
| 2015 |
Hanly EK, Tuli NY, Bednarczyk RB, Suriano R, Geliebter J, Moscatello AL, Darzynkiewicz Z, Tiwari RK. Hyperactive ERK and persistent mTOR signaling characterize vemurafenib resistance in papillary thyroid cancer cells. Oncotarget. PMID 26735176 DOI: 10.18632/Oncotarget.6779 |
0.673 |
|
| 2015 |
George AL, Suriano R, Rajoria S, Osso MC, Tuli N, Hanly E, Geliebter J, Arnold AN, Wallack M, Tiwari RK. PLX4032 Mediated Melanoma Associated Antigen Potentiation in Patient Derived Primary Melanoma Cells. Journal of Cancer. 6: 1320-1330. PMID 26640592 DOI: 10.7150/Jca.11126 |
0.645 |
|
| 2015 |
Hanly EK, Bednarczyk RB, Tuli NY, Moscatello AL, Halicka HD, Li J, Geliebter J, Darzynkiewicz Z, Tiwari RK. mTOR inhibitors sensitize thyroid cancer cells to cytotoxic effect of vemurafenib. Oncotarget. 6: 39702-13. PMID 26284586 DOI: 10.18632/Oncotarget.4052 |
0.46 |
|
| 2015 |
Hanly EK, Darzynkiewicz Z, Tiwari RK. Biguanides and targeted anti-cancer treatments. Genes & Cancer. 6: 82-3. PMID 26000092 DOI: 10.18632/Genesandcancer.59 |
0.391 |
|
| 2015 |
Suriano R, Tuli N, Geliebter J, Tiwari RK, Wallack M. Abstract A30: Small molecule kinase inhibitor mediated modulation of immunotherapy in melanoma Cancer Research. 75. DOI: 10.1158/1538-7445.Mel2014-A30 |
0.652 |
|
| 2015 |
Hanly EK, Tuli NY, Bednarczyk RB, Moscatello AL, Darzynkiewicz Z, Geliebter J, Tiwari RK. Abstract 734: Synergistic antitumor effect of vemurafenib and metformin in thyroid cancer Cancer Research. 75: 734-734. DOI: 10.1158/1538-7445.Am2015-734 |
0.452 |
|
| 2015 |
Jones ME, O'Connell T, Gupta A, Zhao H, Iacob C, Moscatello A, Shin E, Darzynkiewicz Z, Tiwari RK, Geliebter J. Abstract 708: Androgen receptor activation inhibits papillary thyroid carcinoma cell cycle progression Cancer Research. 75: 708-708. DOI: 10.1158/1538-7445.Am2015-708 |
0.47 |
|
| 2015 |
Bednarczyk RB, Kitadai Y, Tuli NY, Hanly EK, Benrahoma G, Mittelman A, Tiwari RK. Abstract 5087: Precise characterization of macrophage secretory exosomes can lead to novel therapeutic approaches Cancer Research. 75: 5087-5087. DOI: 10.1158/1538-7445.Am2015-5087 |
0.463 |
|
| 2015 |
Gupta A, Jones M, Moscatello A, Shin E, Tiwari RK, Geliebter J. Abstract 3926: RhoB expression is upregulated by androgen in thyroid cancer cells Cancer Research. 75: 3926-3926. DOI: 10.1158/1538-7445.Am2015-3926 |
0.479 |
|
| 2015 |
Suriano R, Tuli NY, Geliebter J, Tiwari RK, Wallack M. Abstract 3540: Novel targeted combinational therapies for melanoma Cancer Research. 75: 3540-3540. DOI: 10.1158/1538-7445.Am2015-3540 |
0.587 |
|
| 2015 |
Singh K, Jones M, Moscatello A, Shin E, Tiwari R, Geliebter J. Abstract 1288: Does an increased underlying immune/inflammatory response in healthy females put them at a higher risk for thyroid cancer Immunology. 75: 1288-1288. DOI: 10.1158/1538-7445.Am2015-1288 |
0.384 |
|
| 2014 |
Hanly EK, Rajoria S, Darzynkiewicz Z, Zhao H, Suriano R, Tuli N, George AL, Bednarczyk R, Shin EJ, Geliebter J, Tiwari RK. Disruption of mutated BRAF signaling modulates thyroid cancer phenotype. Bmc Research Notes. 7: 187. PMID 24673746 DOI: 10.1186/1756-0500-7-187 |
0.693 |
|
| 2014 |
Rajoria S, Hanly E, Nicolini A, George AL, Geliebter J, Shin EJ, Suriano R, Carpi A, Tiwari RK. Interlinking of hypoxia and estrogen in thyroid cancer progression. Current Medicinal Chemistry. 21: 1351-60. PMID 24304276 DOI: 10.2174/0929867321666131201142434 |
0.718 |
|
| 2014 |
Tiwari RK, Suriano R, Banerjee D, Konopa J, Geliebter J, Mittelman A. Capridine-β, a new class of chemotherapeutic agents for prostate cancer. Journal of Clinical Oncology. 32: e16062-e16062. DOI: 10.1200/Jco.2014.32.15_Suppl.E16062 |
0.649 |
|
| 2014 |
Suriano R, Tuli N, Geliebter J, Tiwari RK, Wallack MK. Abstract 641: Targeted inhibition of BRAF signaling in melanoma enhances the activity of a multivalent immunotherapeutic vaccine Cancer Research. 74: 641-641. DOI: 10.1158/1538-7445.Am2014-641 |
0.659 |
|
| 2014 |
Reyes N, Correa O, Bettin A, Tiwari RK, Geliebter J. Abstract 4882: Expression profiles of proinflammatory chemokines in prostate cancer cell supernatants Cancer Research. 74: 4882-4882. DOI: 10.1158/1538-7445.Am2014-4882 |
0.461 |
|
| 2014 |
Kitadai R, Bednarczyk R, Tuli N, Hanly E, Benrahoma G, Suriano R, Mittelman A, Tiwari RK. Abstract 3889: Modulation of breast cancer stem cell marker CD44 by all-trans-retinoic acid (ATRA) Cancer Research. 74: 3889-3889. DOI: 10.1158/1538-7445.Am2014-3889 |
0.659 |
|
| 2014 |
Hanly EK, Tuli NY, Suriano R, Bednarczyk R, Darzynkiewicz Z, Moscatello AL, Shin EJ, Geliebter J, Tiwari RK. Abstract 3709: Resistance mechanisms to targeted molecular therapy in thyroid cancer Cancer Research. 74: 3709-3709. DOI: 10.1158/1538-7445.Am2014-3709 |
0.714 |
|
| 2014 |
MacEwan ME, O'Connell T, Zhao H, Iacob C, Suslina N, Moscatello A, Shin E, Tiwari R, Darzynkiewicz Z, Geliebter J. Abstract 2122: Androgen decreases proliferation of thyroid cancer cells Cancer Research. 74: 2122-2122. DOI: 10.1158/1538-7445.Am2014-2122 |
0.448 |
|
| 2014 |
Bednarczyk R, Tuli N, Benrahoma G, Kitadai R, Suriano R, Mittelman A, Tiwari RK. Abstract 1171: Proinflammatory chemokine interleukin-8 in the tumor microenvironment modulates breast cancer phenotype Cancer Research. 74: 1171-1171. DOI: 10.1158/1538-7445.Am2014-1171 |
0.688 |
|
| 2014 |
Tuli NY, Cabin J, Suriano R, Bednarczyk R, Hanly E, Geliebter J, Shin E, Tiwari RK. Abstract 1107: Tumor microenvironment based modulation of thyroid cancer phenotype Cancer Research. 74: 1107-1107. DOI: 10.1158/1538-7445.Am2014-1107 |
0.718 |
|
| 2013 |
Suriano R, Rajoria S, George AL, Geliebter J, Tiwari RK, Wallack M. Follow-up analysis of a randomized phase III immunotherapeutic clinical trial on melanoma. Molecular and Clinical Oncology. 1: 466-472. PMID 24649193 DOI: 10.3892/Mco.2013.97 |
0.579 |
|
| 2013 |
Suriano R, Rajoria S, L George A, Geliebter J, Wallack M, Tiwari RK. Ex vivo derived primary melanoma cells: implications for immunotherapeutic vaccines. Journal of Cancer. 4: 371-82. PMID 23833682 DOI: 10.7150/Jca.6625 |
0.653 |
|
| 2013 |
Suriano R, Rajoria S, George AL, Geliebter J, Wallack M, Tiwari RK. Ex Vivo Derived Primary Melanoma Cells: Implications for Immunotherapeutic Vaccines Journal of Cancer. 4: 371-382. DOI: 10.7150/jca.6625 |
0.572 |
|
| 2013 |
Saman M, Rajoria S, Tuli N, Hanley E, Shin EJ, Tiwari R. The Role of Macrophage-Induced Inflammation in Thyroid Cancer Progression Otolaryngology–Head and Neck Surgery. 149: P192-P192. DOI: 10.1177/0194599813496044A152 |
0.419 |
|
| 2013 |
Rajoria S, Hanly E, George A, Suriano R, Geliebter J, Saman M, Schantz S, Tiwari RK. Abstract 96: Estrogen modulates cellular and molecular markers of hypoxic tumor microenvironment in thyroid cancer. Cancer Research. 73: 96-96. DOI: 10.1158/1538-7445.Am2013-96 |
0.724 |
|
| 2013 |
MacEwan ME, Wong K, Swati I, Xie S, Rasul M, Ardacheva O, Buchsbaum J, Shin E, Moscatello A, Schantz S, Tiwari RK, Geliebter J. Abstract 3559: FKBP5 is an androgen-responsive gene in thyroid cancer cells. Cancer Research. 73: 3559-3559. DOI: 10.1158/1538-7445.Am2013-3559 |
0.458 |
|
| 2013 |
Benedetti I, Correa O, Geliebter J, Tiwari R, Reyes N. Abstract 2870: Prostatic inflammation and proliferative inflammatory atrophy: Are there any associations with prostatic cancer. Cancer Research. 73: 2870-2870. DOI: 10.1158/1538-7445.Am2013-2870 |
0.35 |
|
| 2013 |
Suriano R, George AL, Rajoria S, Geliebter J, Tiwari RK, Wallack M. Abstract 2829: Patient-derived primary melanoma cells that differentially express melano-specific antigens as a model for vaccines. Cancer Research. 73: 2829-2829. DOI: 10.1158/1538-7445.Am2013-2829 |
0.666 |
|
| 2013 |
George AL, Bednarczyk R, Rajoria S, Hanly E, Suriano R, Mittelman A, Tiwari RK. Abstract 1432: CXCL8 is a secretory inflammatory stimulus of the activated TME that modulates breast cancer phenotype. Cancer Research. 73: 1432-1432. DOI: 10.1158/1538-7445.Am2013-1432 |
0.68 |
|
| 2013 |
Hanly EK, Rajoria S, George AL, Suriano R, Geliebter J, Pantelides H, Shin EJ, Tiwari RK. Abstract 1048: Targeted BRAF therapy attenuates the promotional activity of estrogen in thyroid cancer. Cancer Research. 73: 1048-1048. DOI: 10.1158/1538-7445.Am2013-1048 |
0.704 |
|
| 2012 |
George AL, Rajoria S, Suriano R, Mittleman A, Tiwari RK. Hypoxia and estrogen are functionally equivalent in breast cancer-endothelial cell interdependence. Molecular Cancer. 11: 80. PMID 23088607 DOI: 10.1186/1476-4598-11-80 |
0.638 |
|
| 2012 |
Rajoria S, Suriano R, George AL, Kamat A, Schantz SP, Geliebter J, Tiwari RK. Molecular target based combinational therapeutic approaches in thyroid cancer. Journal of Translational Medicine. 10: 81. PMID 22548798 DOI: 10.1186/1479-5876-10-81 |
0.706 |
|
| 2012 |
Shanmugam A, Rajoria S, George AL, Mittelman A, Suriano R, Tiwari RK. Synthetic Toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants. Plos One. 7: e30839. PMID 22363498 DOI: 10.1371/Journal.Pone.0030839 |
0.598 |
|
| 2012 |
Rajoria S, Suriano R, George AL, Shanmugam A, Jussim C, Shin EJ, Moscatello AL, Geliebter J, Carpi A, Tiwari RK. Estrogen activity as a preventive and therapeutic target in thyroid cancer. Biomedicine & Pharmacotherapy = Biomã©Decine & Pharmacothã©Rapie. 66: 151-8. PMID 22285105 DOI: 10.1016/J.Biopha.2011.11.010 |
0.667 |
|
| 2012 |
Kummer NT, Nowicki TS, Azzi JP, Reyes I, Iacob C, Xie S, Swati I, Darzynkiewicz Z, Gotlinger KH, Suslina N, Schantz S, Tiwari RK, Geliebter J. Arachidonate 5 lipoxygenase expression in papillary thyroid carcinoma promotes invasion via MMP-9 induction. Journal of Cellular Biochemistry. 113: 1998-2008. PMID 22253131 DOI: 10.1002/Jcb.24069 |
0.31 |
|
| 2012 |
M. Wong K, Scott Nowicki T, Puccio C, Ahmed T, Tiwari R, Geliebter J, Moscatello A. Clinical Response with Sunitinib Therapy in the Treatment of Anaplastic Thyroid Cancer Journal of Cancer Therapy. 3: 132-136. DOI: 10.4236/Jct.2012.32018 |
0.363 |
|
| 2012 |
MacEwan M, Swati I, Xie S, Ardacheva O, Iacob C, Shin E, Moscatello A, Schantz S, Tiwari RK, Geliebter J. Abstract 3921: Androgens stimulate phosphorylation of ERK and AKT in thyroid cancer cells Cancer Research. 72: 3921-3921. DOI: 10.1158/1538-7445.Am2012-3921 |
0.427 |
|
| 2012 |
Shanmugam A, Rajoria S, George AL, Jussim C, Suriano R, Konopa J, Mittelman A, Tiwari RK. Abstract 3803: Anti-cancer activity of Capridine, a novel nitroacridine chemotherapeutic, in glioblastoma Cancer Research. 72: 3803-3803. DOI: 10.1158/1538-7445.Am2012-3803 |
0.711 |
|
| 2012 |
Jussim C, George AL, Rajoria S, Suriano R, Shanmugam A, Mittelman A, Tiwari RK. Abstract 304: Proinflammatory secretory chemokine CXCL8 regulates intercellular cross-talk in the breast cancer tumor microenvironment Cancer Research. 72: 304-304. DOI: 10.1158/1538-7445.Am2012-304 |
0.697 |
|
| 2012 |
Suriano R, Rajoria S, George A, Jussim C, Shanmugam A, Geliebter J, Tiwari RK, Wallack MK. Abstract 1569: Multivalent melanoma vaccine using primary human melanoma cells and a vaccinia virus based antigen retrieval system Cancer Research. 72: 1569-1569. DOI: 10.1158/1538-7445.Am2012-1569 |
0.671 |
|
| 2012 |
Rajoria S, George A, Suriano R, Shin EJ, Geliebter J, Tiwari RK. Abstract 1520: Estrogen modulates angiogenic factors of thyroid tumor microenvironment Cancer Research. 72: 1520-1520. DOI: 10.1158/1538-7445.Am2012-1520 |
0.721 |
|
| 2012 |
George AL, Rajoria S, Suriano R, Mittelman A, Tiwari RK. Abstract 1494: Intrinsic and extrinsic TME factors modulate breast cancer progression Cancer Research. 72: 1494-1494. DOI: 10.1158/1538-7445.Am2012-1494 |
0.646 |
|
| 2011 |
Rajoria S, Suriano R, Wilson YL, George AL, Geliebter J, Schantz SP, Tiwari RK. Estradiol-mediated tumor neo-vascularization. Oncology Letters. 2: 453-457. PMID 22866102 DOI: 10.3892/Ol.2011.283 |
0.605 |
|
| 2011 |
Darr EA, Patel AD, Yu G, Komorowski Z, McCormick S, Tiwari R, Schantz SP, Geliebter J. Reduced Cx43 gap junction plaque expression differentiates thyroid carcinomas from benign disease. Archives of Otolaryngology--Head & Neck Surgery. 137: 1161-5. PMID 22106244 DOI: 10.1001/Archoto.2011.186 |
0.326 |
|
| 2011 |
Kamat A, Rajoria S, George A, Suriano R, Shanmugam A, Megwalu U, Prakash PB, Tiwari R, Schantz S. Estrogen-mediated angiogenesis in thyroid tumor microenvironment is mediated through VEGF signaling pathways. Archives of Otolaryngology--Head & Neck Surgery. 137: 1146-53. PMID 22106242 DOI: 10.1001/Archoto.2011.194 |
0.664 |
|
| 2011 |
Nowicki TS, Moscatello AL, Shin E, Schantz S, Tiwari RK, Geliebter J. The urokinase plasminogen activator system in metastatic papillary thyroid carcinoma: a potential therapeutic target. The Journal of Clinical Endocrinology and Metabolism. 96: 3062-4. PMID 21832115 DOI: 10.1210/Jc.2011-1123 |
0.361 |
|
| 2011 |
George AL, Bangalore-Prakash P, Rajoria S, Suriano R, Shanmugam A, Mittelman A, Tiwari RK. Endothelial progenitor cell biology in disease and tissue regeneration. Journal of Hematology & Oncology. 4: 24. PMID 21609465 DOI: 10.1186/1756-8722-4-24 |
0.651 |
|
| 2011 |
Shanmugam A, Suriano R, Chaudhuri D, Rajoria S, George A, Mittelman A, Tiwari RK. Identification of PSA peptide mimotopes using phage display peptide library. Peptides. 32: 1097-102. PMID 21539876 DOI: 10.1016/J.Peptides.2011.04.018 |
0.743 |
|
| 2011 |
Rajoria S, Suriano R, George A, Shanmugam A, Schantz SP, Geliebter J, Tiwari RK. Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer. Plos One. 6: e15879. PMID 21267453 DOI: 10.1371/Journal.Pone.0015879 |
0.698 |
|
| 2011 |
Rajoria S, Suriano R, Parmar PS, Wilson YL, Megwalu U, Moscatello A, Bradlow HL, Sepkovic DW, Geliebter J, Schantz SP, Tiwari RK. 3,3'-diindolylmethane modulates estrogen metabolism in patients with thyroid proliferative disease: a pilot study. Thyroid : Official Journal of the American Thyroid Association. 21: 299-304. PMID 21254914 DOI: 10.1089/Thy.2010.0245 |
0.668 |
|
| 2011 |
Nowicki TS, Zhao H, Darzynkiewicz Z, Moscatello A, Shin E, Schantz S, Tiwari RK, Geliebter J. Downregulation of uPAR inhibits migration, invasion, proliferation, FAK/PI3K/Akt signaling and induces senescence in papillary thyroid carcinoma cells. Cell Cycle (Georgetown, Tex.). 10: 100-7. PMID 21191179 DOI: 10.4161/Cc.10.1.14362 |
0.414 |
|
| 2011 |
Rajoria S, Suriano R, Wilson YL, Schantz SP, Moscatello A, Geliebter J, Tiwari RK. 3,3'-diindolylmethane inhibits migration and invasion of human cancer cells through combined suppression of ERK and AKT pathways. Oncology Reports. 25: 491-7. PMID 21152869 DOI: 10.3892/Or.2010.1076 |
0.708 |
|
| 2011 |
Shanmugam A, Suriano R, Goswami N, Chaudhuri D, Ashok BT, Rajoria S, George AL, Mittelman A, Tiwari RK. Identification of peptide mimotopes of gp96 using single-chain antibody library. Cell Stress & Chaperones. 16: 225-34. PMID 20953748 DOI: 10.1007/S12192-010-0234-6 |
0.729 |
|
| 2011 |
Shanmugam A, Rajoria S, George A, Mittelman A, Tiwari RK, Suriano R. Abstract 5396: LPS mimotopes: A novel class of TLR4 agonist Cancer Research. 71: 5396-5396. DOI: 10.1158/1538-7445.Am2011-5396 |
0.557 |
|
| 2011 |
Reyes N, Bettin A, Rebollo J, Tiwari R, Geliebter J. Abstract 5185: Evaluation of biomarker candidate genes for prostate cancer metastasis Cancer Research. 71: 5185-5185. DOI: 10.1158/1538-7445.Am2011-5185 |
0.375 |
|
| 2011 |
George AL, Rajoria S, Shanmugam A, Prakash PB, Suriano R, Tiwari RK. Abstract 1516: Estrogen regulated TME factors are novel modulators of neovasculogenesis and EMT in breast cancer Cancer Research. 71: 1516-1516. DOI: 10.1158/1538-7445.Am2011-1516 |
0.679 |
|
| 2011 |
MacEwan M, Mehta V, Darr EA, Xie S, Nowicki TS, Iacob C, Suslina N, Reyes I, Schantz S, Shin E, Tiwari R, Geliebter J. Abstract 1502: Increased expression of KLK7 and KLK10 in papillary thyroid cancer Cancer Research. 71: 1502-1502. DOI: 10.1158/1538-7445.Am2011-1502 |
0.447 |
|
| 2011 |
Nowicki TS, Zhao H, Darzynkiewicz Z, Moscatello A, Schantz S, Shin E, Tiwari RK, Geliebter J. Abstract 1406: Downregulation of uPAR inhibits migration, invasion, proliferation, FAK/PI3K/Akt signaling, and induces senescence in papillary thyroid carcinoma cells Cancer Research. 71: 1406-1406. DOI: 10.1158/1538-7445.Am2011-1406 |
0.437 |
|
| 2011 |
Rajoria S, George A, Shanmugam A, Kamat A, Schantz SP, Geliebter J, Suriano R, Tiwari RK. Abstract 1320: Estrogen as a modulator of thyroid proliferative disease: Implications for disease etiology and therapy Cancer Research. 71: 1320-1320. DOI: 10.1158/1538-7445.Am2011-1320 |
0.606 |
|
| 2011 |
Darr EA, Nowicki TS, Kummer N, MacEwan M, Dunbar J, Suslina N, Iacob C, Shin E, Schantz S, Tiwari R, Geliebter J. Abstract 1063: BRAFV600Estatus predicts higher uPA levels in papillary thyroid cancer Cancer Research. 71: 1063-1063. DOI: 10.1158/1538-7445.Am2011-1063 |
0.379 |
|
| 2010 |
Nowicki TS, Kummer NT, Iacob C, Suslina N, Schaefer S, Schantz S, Shin E, Moscatello AL, Tiwari RK, Geliebter J. Inhibition of uPAR and uPA reduces invasion in papillary thyroid carcinoma cells. The Laryngoscope. 120: 1383-90. PMID 20578104 DOI: 10.1002/Lary.20915 |
0.348 |
|
| 2010 |
Rajoria S, Suriano R, Shanmugam A, Wilson YL, Schantz SP, Geliebter J, Tiwari RK. Metastatic phenotype is regulated by estrogen in thyroid cells. Thyroid : Official Journal of the American Thyroid Association. 20: 33-41. PMID 20067378 DOI: 10.1089/Thy.2009.0296 |
0.689 |
|
| 2010 |
Rajoria S, George A, Shanmugam A, Megwalu U, Schantz SP, Geliebter J, Tiwari RK, Suriano R. Abstract 5683: The dietary anti-estrogenic agent 3,3′-diindolylmethane inhibits metastatic propensity in thyroid cancer cells Cancer Research. 70: 5683-5683. DOI: 10.1158/1538-7445.Am10-5683 |
0.726 |
|
| 2010 |
Suriano R, Shanmugam A, Rajoria S, George A, Mittelman A, Tiwari RK. Abstract 5628: Synthetic peptide mimics of LPS: Potential role as novel adjuvants Cancer Research. 70: 5628-5628. DOI: 10.1158/1538-7445.Am10-5628 |
0.599 |
|
| 2010 |
Kummer NT, Bedwell J, Nowiki TS, Schantz S, Shin E, Schaefer S, Tiwari RK, Geliebter J. Abstract 529: Matrix metalloproteinase expression and secretion in papillary thyroid carcinoma Cancer Research. 70: 529-529. DOI: 10.1158/1538-7445.Am10-529 |
0.37 |
|
| 2010 |
Nowicki TS, Kummer NT, Iacob C, Suslina N, Moscatello A, Schantz S, Schaefer S, Shin E, Tiwari RK, Geliebter J. Abstract 520: Inhibition of uPAR and uPA reduces invasion and degradative potential in papillary thyroid carcinoma cells Cancer Research. 70: 520-520. DOI: 10.1158/1538-7445.Am10-520 |
0.465 |
|
| 2010 |
Rajoria S, Suriano R, Shanmugam A, Megwalu U, Schantz SP, Geliebter J, Tiwari RK. Abstract 420: Metastatic and neo-vasculature determinants as prognostic markers of thyroid cancer Cancer Research. 70: 420-420. DOI: 10.1158/1538-7445.Am10-420 |
0.709 |
|
| 2010 |
Megwalu U, Suriano R, Shanmugam A, Schantz S, Tiwari R. The effect of DIM on Neovascularization in Thyroid Disease Otolaryngology–Head and Neck Surgery. 143: P74-P74. DOI: 10.1016/J.Otohns.2010.06.104 |
0.607 |
|
| 2009 |
Suriano R, Ghosh SK, Chaudhuri D, Mittelman A, Banerjee A, Tiwari RK. Sialic acid content of tissue-specific gp96 and its potential role in modulating gp96-macrophage interactions. Glycobiology. 19: 1427-35. PMID 19578160 DOI: 10.1093/Glycob/Cwp096 |
0.761 |
|
| 2009 |
Chaudhuri D, Suriano R, Mittelman A, Tiwari RK. Targeting the immune system in cancer. Current Pharmaceutical Biotechnology. 10: 166-84. PMID 19199949 DOI: 10.2174/138920109787315114 |
0.756 |
|
| 2009 |
Wilson Y, Suriano R, Rajoria S, Tiwari R, Schantz S. Role of Estrogen in Thyroid Tumor Neo-Vascularization Otolaryngology–Head and Neck Surgery. 141: P57-P58. DOI: 10.1016/J.Otohns.2009.06.172 |
0.63 |
|
| 2008 |
Suriano R, Chaudhuri D, Johnson RS, Lambers E, Ashok BT, Kishore R, Tiwari RK. 17Beta-estradiol mobilizes bone marrow-derived endothelial progenitor cells to tumors. Cancer Research. 68: 6038-42. PMID 18676823 DOI: 10.1158/0008-5472.Can-08-1009 |
0.733 |
|
| 2007 |
Tadi K, Ashok BT, Chen Y, Banerjee D, Wysocka-Skrzela B, Konopa J, Darzynkiewicz Z, Tiwari RK. Pre-clinical evaluation of 1-nitroacridine derived chemotherapeutic agent that has preferential cytotoxic activity towards prostate cancer. Cancer Biology & Therapy. 6: 1632-7. PMID 17921700 DOI: 10.4161/Cbt.6.10.4790 |
0.411 |
|
| 2007 |
Reyes I, Tiwari R, Geliebter J, Reyes N. DNA microarray analysis reveals metastasis-associated genes in rat prostate cancer cell lines. BioméDica : Revista Del Instituto Nacional De Salud. 27: 190-203. PMID 17713630 |
0.315 |
|
| 2007 |
Ashok BT, Tadi K, Garikapaty VP, Chen Y, Huang Q, Banerjee D, Konopa J, Tiwari RK. Preclinical toxicological examination of a putative prostate cancer-specific 4-methyl-1-nitroacridine derivative in rodents. Anti-Cancer Drugs. 18: 87-94. PMID 17159506 DOI: 10.1097/01.Cad.0000236316.04199.20 |
0.774 |
|
| 2007 |
Reyes I, Tiwari R, Geliebter J, Reyes N. Análisis de micromatrices de ADN revela genes asociados a metástasis en líneas celulares de cáncer de próstata de rata BioméDica. 27: 192. DOI: 10.7705/Biomedica.V27I2.215 |
0.411 |
|
| 2006 |
Ashok BT, Tadi K, Banerjee D, Konopa J, Iatropoulos M, Tiwari RK. Pre-clinical toxicology and pathology of 9-(2'-hydroxyethylamino)-4-methyl-1-nitroacridine (C-1748), a novel anti-cancer agent in male Beagle dogs. Life Sciences. 79: 1334-42. PMID 16712873 DOI: 10.1016/J.Lfs.2006.03.043 |
0.336 |
|
| 2006 |
Suriano R, Lin Y, Ashok BT, Schaefer SD, Schantz SP, Geliebter J, Tiwari RK. Pilot study using SELDI-TOF-MS based proteomic profile for the identification of diagnostic biomarkers of thyroid proliferative diseases. Journal of Proteome Research. 5: 856-61. PMID 16602693 DOI: 10.1021/pr050349r |
0.586 |
|
| 2006 |
Garikapaty VP, Ashok BT, Tadi K, Mittelman A, Tiwari RK. 3,3'-Diindolylmethane downregulates pro-survival pathway in hormone independent prostate cancer. Biochemical and Biophysical Research Communications. 340: 718-25. PMID 16380095 DOI: 10.1016/J.Bbrc.2005.12.059 |
0.793 |
|
| 2006 |
Garikapaty VP, Ashok BT, Tadi K, Mittelman A, Tiwari RK. Synthetic dimer of indole-3-carbinol: second generation diet derived anti-cancer agent in hormone sensitive prostate cancer. The Prostate. 66: 453-62. PMID 16353249 DOI: 10.1002/Pros.20350 |
0.786 |
|
| 2005 |
Kanduc D, Geliebter J, Lucchese A, Mazzanti R, Mittelman A, Polimeno L, Ponzetto A, Santacroce R, Simone S, Sinigaglia E, Sinha AA, Tessitore L, Tiwari RK, Farber E. Gene therapy in cancer: the missing point. Journal of Experimental Therapeutics & Oncology. 5: 151-8. PMID 16471041 |
0.308 |
|
| 2005 |
Tadi K, Chang Y, Ashok BT, Chen Y, Moscatello A, Schaefer SD, Schantz SP, Policastro AJ, Geliebter J, Tiwari RK. 3,3'-Diindolylmethane, a cruciferous vegetable derived synthetic anti-proliferative compound in thyroid disease. Biochemical and Biophysical Research Communications. 337: 1019-25. PMID 16219298 DOI: 10.1016/J.Bbrc.2005.09.143 |
0.408 |
|
| 2005 |
Suriano R, Ghosh SK, Ashok BT, Mittelman A, Chen Y, Banerjee A, Tiwari RK. Differences in glycosylation patterns of heat shock protein, gp96: implications for prostate cancer prevention. Cancer Research. 65: 6466-75. PMID 16024652 DOI: 10.1158/0008-5472.Can-04-4639 |
0.669 |
|
| 2005 |
Garikapaty VP, Ashok BT, Chen YG, Mittelman A, Iatropoulos M, Tiwari RK. Anti-carcinogenic and anti-metastatic properties of indole-3-carbinol in prostate cancer. Oncology Reports. 13: 89-93. PMID 15583807 DOI: 10.3892/Or.13.1.89 |
0.785 |
|
| 2004 |
Reyes N, Reyes I, Tiwari R, Geliebter J. Effect of linoleic acid on proliferation and gene expression in the breast cancer cell line T47D. Cancer Letters. 209: 25-35. PMID 15145518 DOI: 10.1016/J.Canlet.2003.12.010 |
0.371 |
|
| 2003 |
Chen YG, Ashok BT, Liu X, Garikapaty VP, Mittelman A, Tiwari RK. Induction of heat shock protein gp96 by immune cytokines. Cell Stress & Chaperones. 8: 242-8. PMID 14984057 DOI: 10.1379/1466-1268(2003)008<0242:Iohspg>2.0.Co;2 |
0.761 |
|
| 2003 |
Kanduc D, Capuano F, Capurso SA, Geliebter J, Guercia D, Lucchese A, Mittelman A, Simone SM, Sinha AA, Tiwari R, Farber E. Cancer prevention and therapy: strategies and problems. Journal of Experimental Therapeutics & Oncology. 3: 108-14. PMID 14641817 DOI: 10.1046/J.1359-4117.2003.01086.X |
0.403 |
|
| 2003 |
Ashok BT, David L, Chen YG, Garikapaty VP, Chander B, Kanduc D, Mittelman A, Tiwari RK. Peptide mimotopes of oncoproteins as therapeutic agents in breast cancer. International Journal of Molecular Medicine. 11: 465-71. PMID 12632099 DOI: 10.3892/Ijmm.11.4.465 |
0.76 |
|
| 2002 |
Ashok BT, Chen YG, Liu X, Garikapaty VP, Seplowitz R, Tschorn J, Roy K, Mittelman A, Tiwari RK. Multiple molecular targets of indole-3-carbinol, a chemopreventive anti-estrogen in breast cancer. European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (Ecp). 11: S86-93. PMID 12570340 |
0.754 |
|
| 2001 |
Ashok BT, Chen Y, Liu X, Bradlow HL, Mittelman A, Tiwari RK. Abrogation of estrogen-mediated cellular and biochemical effects by indole-3-carbinol. Nutrition and Cancer. 41: 180-7. PMID 12094623 DOI: 10.1080/01635581.2001.9680630 |
0.382 |
|
| 2001 |
Ashok BT, Kim E, Mittelman A, Tiwari RK. Proteasome inhibitors differentially affect heat shock protein response in cancer cells. International Journal of Molecular Medicine. 8: 385-90. PMID 11562776 DOI: 10.3892/Ijmm.8.4.385 |
0.375 |
|
| 2001 |
Geliebter J, Mittelman A, Tiwari RK. PC-SPES and prostate cancer Journal of Nutrition. 131. PMID 11208956 DOI: 10.1093/Jn/131.1.164S |
0.38 |
|
| 1999 |
Tiwari RK, Geliebter J, Garikapaty VP, Yedavelli SP, Chen S, Mittelman A. Anti-tumor effects of PC-SPES, an herbal formulation in prostate cancer. International Journal of Oncology. 14: 713-9. PMID 10087319 DOI: 10.3892/Ijo.14.4.713 |
0.786 |
|
| 1997 |
Bradlow HL, Davis D, Sepkovic DW, Tiwari R, Osborne MP. Role of the estrogen receptor in the action of organochlorine pesticides on estrogen metabolism in human breast cancer cell lines. Science of the Total Environment. 208: 9-14. PMID 9496644 DOI: 10.1016/S0048-9697(97)00287-8 |
0.402 |
|
| Show low-probability matches. |